Patient-relevant endpoints in inflammatory bowel diseases--have changes occurred in Germany over the past twelve years?

Journal of Crohn's & colitis

Volumn 9, Issue 5, 2015, Pages 390-397

  Stallmach, Andreas ^a   Dennler, Ulf ^a   Marschall, Ursula ^a   Schmidt, Carsten ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

antibodies; immunosuppression; Inflammatory bowel disease; morbidity; mortality; outcome

Indexed keywords

TUMOR NECROSIS FACTOR;

ABDOMINAL SURGERY; ADOLESCENT; ADULT; AGED; ANTAGONISTS AND INHIBITORS; BIOASSAY; COLITIS, ULCERATIVE; CROHN DISEASE; EPIDEMIOLOGY; FEMALE; GERMANY; HOSPITALIZATION; HUMAN; LIFE EXPECTANCY; MALE; MEDICAL LEAVE; MIDDLE AGED; MORTALITY; RETIREMENT; TRENDS; WORK CAPACITY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; COLITIS, ULCERATIVE; CROHN DISEASE; DIGESTIVE SYSTEM SURGICAL PROCEDURES; ENDPOINT DETERMINATION; FEMALE; GERMANY; HOSPITALIZATION; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; RETIREMENT; SICK LEAVE; TUMOR NECROSIS FACTOR-ALPHA; WORK CAPACITY EVALUATION; YOUNG ADULT;

EID: 84991238610     PISSN: None     EISSN: 18764479     Source Type: Journal    
DOI: 10.1093/ecco-jcc/jjv041     Document Type: Article

References (0)